SAMDaily.us | SNOTE | 65 | J&A ERVEBO

SAMDAILY.US - ISSUE OF OCTOBER 09, 2024 SAM #8352
SPECIAL NOTICE

65 -- J&A ERVEBO

Notice Date: 10/7/2024 10:48:16 AM
Notice Type: Justification
NAICS: 325412 — Pharmaceutical Preparation Manufacturing
Contracting Office: BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
ZIP Code: 20515
Solicitation Number: 75A50124C00057
Archive Date: 11/06/2024
Point of Contact: Yifan Yang
E-Mail Address: yifan.yang@hhs.gov
(yifan.yang@hhs.gov)
Award Number: 75A50124C00057
Award Date: 09/27/2024
Description: This is a Justification & Approval (J&A) in accordance with FAR 6.302-1 Only one responsible source and no other supplies or services will satisfy agency requirements.��This acquisition will allow BARDA to invest Project Bioshield funds for the procurement of a FDA licensed Zaire ebolavirus vaccine, ERVEBO; final drug product stored in vendor managed inventory (VMI) and; development of an updated manufacturing process.
Web Link: SAM.gov Permalink
(https://sam.gov/opp/67fd4ef2b71641f5b7c06049ff893a19/view)
Place of Performance: Address: Rahway, NJ, USA; Country: USA
Record: SN07234663-F 20241009/241007230104 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |